ORIGINAL RESEARCH article

Front. Anesthesiol., 22 November 2022

Sec. Cardiothoracic Anesthesiology

Volume 1 - 2022 | https://doi.org/10.3389/fanes.2022.990391

Airway management with novel intubating laryngeal tubes has no influence on cerebral oxygenation in cardiac surgery patients: A prospective observational study

  • MK

    Marc Kriege 1*

  • RR

    René Rissel 1

  • FH

    Florian Heid 1

  • TO

    Thomas Ott 1

  • HE

    Hazem El Beyrouti 2

  • EH

    Eric Hotz 1

  • 1. Department of Anesthesiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

  • 2. Department of Cardiac and Vascular Surgery, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

Abstract

Background:

A laryngeal tube is often used as an alternative to intubation with direct laryngoscopy during cardiopulmonary resuscitation. However, in a study with piglets undergoing simulated cardiac arrest, reduced carotid artery blood flow was associated with the insertion of different supraglottic airway devices, such as a laryngeal tube. Limited by its construction, secondary tracheal intubation through a laryngeal tube was difficult or impossible in contrast to a second generation laryngeal mask. The new disposable intubating laryngeal tube with suction (iLTS-D®) seems to facilitate tracheal intubation. We hypothesized that iLTS-D, when inflated to the recommended air volume, does not reduce cerebral oxygenation in patients with cardiovascular diseases undergoing elective cardiac surgery.

Methods:

This single-center prospective, controlled observational study was approved by the local ethics committee (Ethical Committee No. 2018-13716). Forty adult patients undergoing elective cardiac surgery requiring tracheal intubation were included in this study. The exclusion criteria were age <18 years and a high risk of aspiration, inability to consent, height <155 cm, or pregnancy. Prior to insufflation and deflation of the cuffs, we performed cerebral oximetry via near-infrared spectroscopy. The primary outcome was a significant reduction in NIRS in the context of the preinduction baseline value after inflation of the cuffs with the recommended air volume, defined as a ≥25% decrease from baseline or an absolute value ≤ 50%. The secondary endpoints were differences in time points, insertion success rates, and complications.

Results:

There was no significant reduction in cerebral oximetry after inflation with the recommended cuff volume and an initially measured cuff pressure of >120 cmH2O. Overall, tracheal intubation was achieved in a median of 20 s [interquartile range 15-23 s] and enabled sufficient ventilation and tracheal intubation through the iLTS-D in all patients. Traces of blood on the cuffs (after removing the iLTS-D) and a sore throat (evaluated 2 h after removing the tracheal tube) were observed in one patient.

Conclusion:

Our results showed no association between the insertion of the iLTS-D and reduced cerebral oxygenation in patients undergoing elective cardiac surgery.

Trial registration:

ClinicalTrials.gov, NCT03942809.

Introduction

The laryngeal tube is a standard supraglottic airway device routinely used during cardiopulmonary resuscitation or difficult airway management during in-hospital and out-of-hospital emergencies []. In a cluster-crossover trial of 3,004 adults with out-of-hospital cardiac arrest, an initial laryngeal tube insertion was associated with a significantly higher 72 h survival compared to tracheal intubation by emergency medical services []. The advantage of the laryngeal tube is easier handling (blindly placed) than tracheal intubation with direct laryngoscopy, without the need to stop chest compressions during cardiac arrest []. Therefore, several guidelines recommend the use of laryngeal tubes as a rescue technique in the event of failed tracheal intubation [].

Despite this recent shift in airway management practice, little is known about the potential effects of laryngeal tubes on cervical vessels and any associated cerebral hemodynamic effects. The proximal (oropharyngeal) balloon is designed to seal the pharynx above the ventilation port, and the distal (esophageal) balloon is designed to seal the airway distally. The clinical effects of cuff insufflation on the cervical vessels were first studied by Colbert et al. []. This study concluded that the cross-sectional area of both carotid arteries significantly decreased after inflation of the laryngeal mask cuff, which was compensated by an increase in flow velocity and carotid blood flow []. Reduction in the carotid artery diameters was more marked in patients older than 60 years, where the cross-sectional area dropped after inflation by more than 60% when compared with the area measured during cuff deflation []. Segal et al. showed in a study with young pigs (32 kg) under experimental cardiac arrest an association between three supraglottic airway devices (laryngeal tube, laryngeal mask and Combi tube) and a significant reduction in carotid blood flow []. Eismann et al. observed no difference in flow velocity during cuff inflation of the laryngeal tube and a second-generation laryngeal mask in older patients without a diagnosed carotid stenosis of > 50% []. This study excluded patients with carotid artery stenosis >50% of internal diameter and American Society of Anesthesiologists status (ASA) 4.

However, secondary intubation (blind or with a bougie) through a placed laryngeal tube is either difficult or impossible. The novel disposable intubating laryngeal tube with suction (iLTS-D; VBM® Medizintechnik GmbH, Sulz, Germany) was used to study intubation performance in patients undergoing elective surgery [] and a simulated airway []. The manufacturer recommends endoscopic-guided tracheal intubation, although several studies have reported successful blind tracheal intubation through the iLTS-D []. The new version presents a different localization of the proximal cuff and a softer material. We hypothesized that iLTS-D after inflated to the recommended air volume does not reduce cerebral oxygenation in patients with cardiovascular diseases undergoing elective cardiac surgery.

The aim of this study was to evaluate whether the new iLTS-D is associated with a significant reduction in cerebral oxygenation in patients with cardiovascular disease undergoing cardiac surgery under general anesthesia.

Methods

Ethics

Data were collected between May 2019 and April 2020 at the University Medical Center, Mainz, Germany. Ethics approval for this study (Ethical Committee No. 2018-13716) was provided by the Ethical Committee of the Medical Association of the Rhineland Palatine State, Germany (Chairperson Dr. A. Wagner) on 18 May. Written informed consent was obtained from all of the patients.

Study design

We designed a prospective, observational study of surgical patients (Department of Cardiac and Vascular Surgery) undergoing general anesthesia at a tertiary university hospital (Clinical Trial Register number NCT03942809).

Participants

The inclusion criteria were adult patients scheduled for elective cardiac surgery under general anesthesia requiring mechanical ventilation via an tracheal tube. We excluded patients if they had an increased risk of pulmonary aspiration, inability to consent, height <155 cm, or were pregnant (Figure 1).

Figure 1

Study settings and measurements

The iLTS-D has been recently modified and is an improved version of the laryngeal tube. The insertion technique is similar to the laryngeal tube. The ventilation orifice is shaped like a “ramp” within the canal to guide the tracheal tube at a steep angle in the direction of the glottis.

The novel iLTS-D is currently available in an adult size, which fits classical laryngeal tube sizes 4 and 5 simultaneously, with two separate marks positioned at the upper front teeth level to define the optimal depth of insertion. The cuffs are inflated with a syringe using the air volume recommended by the manufacturer (the syringe is color-coded by the manufacturer). After placement, the cuff pressure is controlled with a cuff pressure manometer (VBM® Cuff pressure gauge; VBM Medizintechnik, Sulz, Germany). In this trial, we used the aScope™ 4 Regular (Ambu®, Ballerup, Denmark) for endoscopically guided tracheal intubation. The proximal end of the gastric tube is shaped like a small cone for ease of insertion. The manufacturer provides a rigid plastic “pusher” to allow for the removal of the iLTS-D while the tracheal tube is kept in place (Figure 2).

Figure 2

All patients underwent standard invasive anesthesia monitoring, bispectral analysis monitoring, and near-infrared spectroscopy (NIRS). NIRS cerebral profiles were collected during the procedure using a 2-wavelength (730–810 nm) cerebral oximeter (monitor INVOS 5100C®, Covidien, Medtronic's, USA) to record the regional cerebral oxygen saturation (rScO2). The NIRS optodes were placed on the left frontoparietal side of the patient's head. NIRS is an indirect indicator of perfusion adequacy. Therefore, it provides continuous information on the oxygen supply vs. demand balance. NIRS utilizes the transparency of the scalp and skull to infrared light and the differences in the absorption spectra between oxyhemoglobin and deoxyhemoglobin to quantify the local oxygen saturation of hemoglobin in the brain. Several of the influencing factors include the perfusion pressure, arterial oxygen content, partial pressure of carbon dioxide, hemoglobin, cardiac output, and cerebral metabolic rate of oxygen []. Normal values for the NIRS are between 60-75%, but physiological values of 55-60% have been reported in cardiac patients []. Therefore, trends in the values are considered more important in clinical practice than the absolute values of rScO2.

Before induction of general anesthesia, the baseline value for each patient was recorded while the patient was still awake, and this baseline was considered the individual reference value. After sufficient preoxygenation (etO2 > 90%), general anesthesia was induced with sufentanil (0.5 μg.kg−1) and propofol (1–2 mg.kg−1), and anesthesia was maintained using either propofol infusion (3-4 mg.kg−1) or volatile anesthetics at a minimal alveolar concentration between 0.8 and 1.0. All patients were pressure-controlled ventilated with a tight-fitting face mask to reach normocapnia (expiratory carbon dioxide between 35 and 45 mmHg), as displayed by the anesthesia respirator (Draeger® Pallas, Luebeck, Germany). Once deep anesthesia (bispectral index <60) and administration of a sufficient dose of a neuromuscular blocking agent (Rocuronium 1 mg.kg−1) were confirmed, the iLTS-D was inserted according to the manufacturer's recommendations. All patients were anesthetized by an experienced cardiac anesthesiologist with prior experience with iLTS-D or laryngeal tubes.

The primary outcome was a significant reduction in NIRS in the context of the preinduction baseline value after inflation of the cuffs with the recommended air volume, defined as a ≥25% decrease from baseline or an absolute value ≤ 50%. NIRS was measured at three time points: (i) baseline, (ii) after anesthesia induction, and (iii) after the initial inflation of the cuffs. NIRS was measured at each time point after three cardiac cycles. The time to insertion, time to ventilation with the iLTS-D, time to tracheal intubation (both times were stopped after inflection of the capnography wave), time to removal of the iLTS-D, success rate of the iLTS-D insertion and tracheal intubation (defined as within <60 s), glottis visualization, and complications were defined as secondary endpoints. For endoscopic-guided tracheal intubation, the best endoscopic views were graded from 1 to 4: 1 = vocal cords entirely visible; 2 = vocal cords or arytenoid cartilages partially visible; 3 = epiglottis only visible; and 4 = no laryngeal structures visible []. Capnography confirmed successful iLTS-D insertion and tracheal tube placement. After correct tracheal tube placement, the iLTS-D was removed using the rigid “pusher”. An additional study nurse not involved in patient care was present during the induction of anesthesia to record study parameters.

Statistical analyses

Sample size calculation was performed using G*Power 3.1 []. A sample size of 40 was calculated assuming an alpha error of 5% and a power of 90%. All collected data were processed using GraphPad Prism 9.0 h (GraphPad® Software Inc., USA). Data were tested for a normal distribution (Shapiro–Wilk normality test) and are presented as the mean and standard deviation (SD) for a normal distribution or as median and interquartile range [IQR] for a nonnormal distribution. Differences in NIRS and the time intervals were calculated using the Wilcoxon signed-rank test. Statistical significance was set at a P-value < 0.05.

Results

Forty patients were enrolled in this study (Figure 1). Patient characteristics are described in Table 1.

Table 1

All patients, n = 40
Age (years)71 [64–76]
Male: Female24:16 (60%:40%)
BMI (kg.cm−2)27.15 [24.25–33.38]
ASA 3/45/35
Hemoglobin concentration (g.dl−1)11.3 [10.1–13.5]
Airway evaluation
Mallampati classification 1/2/3/42/28/9/1
Thyromental distance <6.5 cm10 (25%)
Status of teeth: fix/poor/loose24/12/4
Head and neck movement <35 degree16 (40%)
Comorbidities
Hypertension36 (90%)
COPD18 (45%)
OSAS12 (30%)
Typ 2 Diabetes10 (25%)
Cardiovascular disease40 (100%)
Carotid macro angiopathy13 (32%)
Internal carotid artery stenosis >50%27 (68%)
Surgery type
CABG20 (50%)
Heart valve repair20 (50%)

Baseline patient characteristics presented as numbers (proportion) or median [IQR].

BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; OSAS, obstructive sleep apnea syndrome; CABG, coronary aortic bypass graft.

The first attempt to insert the iLTS-D was successful in all patients. After inflation with the recommended cuff volume, a cuff pressure of 110 [90–120] cmH2O was measured. The oropharyngeal leak pressure was 25 [24–28] cmH2O with a cuff pressure of 50 [50–60] cmH2O. Therefore, we evacuated a cuff volume of 12 ml [8–15] to decrease the initial measured cuff pressure to 60 cmH2O. The NIRS data are presented in Figure 3. NIRS median values before (T0) 72% [70–73], after anesthesia induction (T1) 74% [70–72] and after insertion of the iLTS-D (T2) with inflation of the cuffs at 70% [70–74] were similar (P = 0.31). The perioperative characteristics are shown in Table 2.

Figure 3

Table 2

Insertion of iLTS-DTracheal intubationRemoval of the iLTS-D
Hemodynamic
Systolic arterial pressure (mmHg)136 [130–145]135 [125–143]135 [129–143]
Diastolic arterial pressure (mmHg)57 [55–65]55 [55–59]59 [55–61]
Mean arterial pressure (mmHg)72 [70–76]72 [70–74]72 [70–75]
Heart rate (min−1)80 [74–82]76 [75–80]76 [72–79]
Success
First attempt40/40 (100%)38/40 (95%)40/40 (100%)
Second attempt2/40 (5%)
Time points (seconds)11 [10–13]20 [18–22]29 [27–32]
Endoscopic view 1/2/3/435/4/1/0
Placement test
Suprasternal notch test40 (100%)
Bubble test40 (100%)
Insertion of 16 Fr gastric tube40 (100%)

Peri-operative characteristics presented as numbers (proportion) or median [IQR].

Endoscopic view of the glottic: 1, vocal cords entirely visible; 2, vocal cords or arytenoid cartilages partially visible; 3, epiglottis only visible; 4, no laryngeal structures visible.

Endoscopic guided intubation at the first attempt was successful in 38/40 (95%) patients. In two (5%) patients with difficult visualization of the laryngeal structures (one patient with only the epiglottis visible and one patient with no visible laryngeal structures), intubation was possible after correcting the position of the iLTS-D, guided by visualization with the video endoscope. After removal of the iLTS-D over the tracheal tube, no traces of blood at the iLTS-D cuff or dental/lip lesions were observed. Desaturation did not occur during or after any step in this study. One female patient complained of a sore throat 2 h after tracheal extubation in the intensive care unit.

Discussion

This study showed no significant differences in regional cerebral oxygen saturation measured by NIRS as an indirect indicator of cerebral perfusion using the novel iLTS-D in patients with cardiovascular disease undergoing elective cardiac surgery. To the best of our knowledge, this is the first study evaluating the potential for impaired cerebral oxygenation during use of the iLTS-D as a supraglottic airway device in patients undergoing cardiac surgery.

The patient characteristics in this study were consistent with those of previous studies evaluating iLTS-D in a clinical setting []. Different from other studies, we included ASA 4 patients with changes in their cervical vessels (e.g., carotid artery stenosis). Our findings are in contrast to one study suggesting a significant reduction in carotid artery blood flow when using a laryngeal tube []. However, the authors investigated piglets with a weight of 32 kg and limited transferability to human conditions. Furthermore, their measurements were obtained during cardiac arrest and not during hemodynamic stability. A study in humans investigating different supraglottic airway devices yielded heterogeneous results, as the laryngeal tube was not associated with impaired internal carotid artery blood flow during general anesthesia in adult patients with an ASA ≤ 3 and without diagnosed carotid stenosis >50% [].

Otherwise, one study demonstrated that inflation with a fixed cuff volume (without a cuff pressure measurement) of a laryngeal mask resulted in a decrease in the cross-sectional area and a decrease in blood flow in the common carotid bulb in adult patients <55 years with an ASA ≤ 3 []. Sulzgruber et al. showed a poor 30-day survival rate (8.9 vs. 15.8%) in patients with out-of-hospital cardiac arrest and the use of laryngeal tubes compared to tracheal intubation []. Interestingly, Whang et al. showed a higher 72 h survival rate (18.3 vs. 15.4%), successful initial airway insertion (44.1 vs. 11.8%), and faster return of spontaneous circulation (27.9 vs. 24.3%) in the laryngeal tube group than in the tracheal intubation group []. The authors explained the different survival rates by provider experience (paramedics vs. emergency physicians), adequate chest compressions or sufficient ventilation and aspiration, or crossover timings.

First-pass success for the iLTS-D insertion was comparable with existing studies that investigated iLTS-D in humans or manikins (98–100% []). Noticeable in clinical settings, more correction maneuvers (2–4 maneuvers) are necessary to improve ventilation after iLTS-D insertion [, ]. Manikin-based studies are not directly transferable to humans because of the simulated airway anatomy. Additionally, a possibly harmful overestimation of the clinical capability of inexperienced participants after simulator training was reported []. In this current trial, 95% of video endoscope-guided tracheal intubations were successful on the first attempt. In 5% of patients, the reason for failed intubation was the tracheal tube being hindered from moving forward in the device due to impingement of the tracheal tube against the laryngeal structure (e.g., arytenoid cartilages). In accordance with other studies, we observed two patients with limited visualization of the glottic structures graded III–IV with the need for a second attempt []. Blind intubation in humans at the first attempt has inconsistent success, ranging from 13 to 65% []. One study reported a success rate of blind intubation through an iLTS-D of 65% and a high leak pressure (mean 39.6 cmH2O) in extremely obese patients []. Correct alignment of the cuffs and ventilation orifice of the iLTS-D has been reported as essential, hence resulting in a strong recommendation to use endoscopic assistance for guided tracheal intubation via a supraglottic airway device [, , ]. The specific time measurements were comparable to the existing data in clinical or simulated-based studies []. Interestingly, the definition of “intubation time” varies among studies. Either the time was stopped after the chest rose [, ] or inflection on the expired waveform capnography []. In contrast to the study by Reviriego-Agudo et al. [], we observed no bloodstains after removal of the iLTS-D and a lower frequency of sore throat [, , ]. A possible reason might be the dispensation of blind attempts in combination with a high first-pass success rate.

Limitations

The current study had several limitations. First, the design was observational, single-center, and included only one type of supraglottic airway device. Second, all investigators had sufficient clinical experience with the iLTS-D for both iLTS-D insertions and tracheal intubation, which probably does not reflect daily practice. To the best of our knowledge, there are no data on the learning curve of the iLTS-D. In addition, the number of analyzed patients might have been too small to identify relevant effects in changes in the cerebral oxygenation, hemodynamics or rate of complications with the iLTS-D. Otherwise, we recorded a high insertion and intubation first-pass success rate in this small patient group. Third, we documented cerebral oxygenation using NIRS, which may not have detected previously described reductions in the carotid artery diameter or blood flow. Fourth, the recommended use of a flexible endoscope to guide the intubation changes the configuration of the intubation technique compared to the intubating laryngeal mask (e.g., Fastrach™). Although the latter was not routinely used to guide the intubation, it might have changed the ease and success rate of the intubation. Fifth, we used a standardized assessment after anesthesia induction and one neuromuscular blockade to ensure optimal conditions for iLTS-D insertion. In contrast to our study, many anesthesiologists or paramedics use laryngeal tubes out-of-hospital in patients with cardiac arrest. In these cases, the conditions of the tongue muscle tone and laryngeal airway reflexes are comparable with our study setting, but our findings do not apply to patients with cardiac arrest.

Conclusion

This observational study showed no impairment of cerebral oxygenation by the novel iLTS-D in patients with cardiovascular disease undergoing cardiac surgery. Advantages of this new device include a high first-pass success rate, high oropharyngeal leak pressure, and in combination with video endoscope guidance, facilitated tracheal intubation, both of which demonstrate benefits for clinical practice. Further comparative studies, especially under low-flow perfusion or cardiac arrest, are needed to exclude any detrimental effects of supraglottic airway devices in humans.

Funding

This trial was supported by a local grant from the Department of Anesthesiology. No company supported this trial financially or was involved in the study design, data collection, analysis, or interpretation of the results. No other funding or competing interests were declared.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Author’s note

This manuscript is our original unpublished work and has not been submitted to any other journal. Parts of this study have been presented as a poster presentation at the European Society for Airway Management Congress (EAC) 2018, Valencia, Spain.

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.

Ethics statement

Ethical approval for this study (Ethical Committee No. 2018-13716) was provided by the Ethical Committee of the Medical Association of the Rhineland Palatine State, Germany (Chairperson Dr. A. Wagner) on 18 May. Written informed consent was obtained from all the patients. The patients/participants provided their written informed consent to participate in this study.

Author contributions

MK is the guarantor of the paper. All authors meet the criteria for authorship as recommended by the International Committee of Medical Journal Editors. All authors contributed to the production of the final manuscript with revision for important intellectual content.

Acknowledgments

The authors would like to thank all anesthesiologists and nurses for their assistance in conducting this clinical trial.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fanes.2022.990391/full#supplementary-material

References

Summary

Keywords

oxygen saturation, endotracheal intubation, airway management, hemodynamic monitoring, anesthesia, cardiac procedures

Citation

Kriege M, Rissel R, Heid F, Ott T, Beyrouti HE and Hotz E (2022) Airway management with novel intubating laryngeal tubes has no influence on cerebral oxygenation in cardiac surgery patients: A prospective observational study. Front. Anesthesiol. 1:990391. doi: 10.3389/fanes.2022.990391

Received

09 July 2022

Accepted

05 October 2022

Published

22 November 2022

Volume

1 - 2022

Edited by

Giovanni Landoni, San Raffaele Hospital (IRCCS), Italy

Reviewed by

Wael Saasouh, Detroit Medical Center, United States; Silvia Delrio, University of Udine, Italy

Updates

Copyright

*Correspondence: Marc Kriege

This article was submitted to Cardiothoracic Anesthesiology, a section of the journal Frontiers in Anesthesiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics